# OnCo record nct05949125 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05949125/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05949125", "NCT05949125" ;
  schema:name "Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies (1b Dose Expansion)"@en ;
  schema:description "A phase 1 trial of AVC-201 run by AvenCell Europe GmbH, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05949125/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05949125> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:drugs <https://onco.cc/drugs/avc-201/> ;
  onco:companies <https://onco.cc/companies/avencell-therapeutics/> .